Methyl nicotinate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Methyl nicotinate Product Information
Methyl nicotinate is listed under Intermediate and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Nicotine. The product is supplied by Clearsynth under CAT No. CS-T-34479.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Methyl nicotinate
CAS No.
93-60-7
CAT No.
CS-T-34479
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C7H7NO2
Molecular Weight
137.1
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Methyl nicotinate is supplied with detailed characterization data compliant with regulatory guideline. Methyl nicotinate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Nicotine.
Overview
Methyl Nicotinate is a useful synthetic intermediate. It can be used to prepare biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-a in treatment of rheumatoid arthritis.
Synonyms
Methyl nicotinate
Application Notes
Methyl Nicotinate is a useful synthetic intermediate. It can be used to prepare biarylcarboxamide inhibitors of phosphodiesterase IV and tumor necrosis factor-a in treatment of rheumatoid arthritis.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.